AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34124817 — intervention group
Group type: EXPERIMENTAL
Intervention: Salivary IgA antibodies to A. actinomycetemcomitans
Number of subjects: 423
Study 34124817 — intervention group
Group type: EXPERIMENTAL
Intervention: Salivary IgA antibodies to P. intermedia
Number of subjects: 423
Study 34124817 — intervention group
Group type: EXPERIMENTAL
Intervention: Total IgA
Number of subjects: 423
Study 32915512 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (4000 IU daily)
Number of subjects: 200
Study 32915512 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study 33638577 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiomics signature comprising five handcrafted and one deep learning-based features
Number of subjects: 97
Study 32529343 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual care with QoL-monitor
Number of subjects: 113
Study 32529343 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 113
Study 36256912 — intervention group
Group type: EXPERIMENTAL
Intervention: Cediranib 30 mg once daily plus olaparib 200 mg twice daily
Number of subjects: 90
Study 36256912 — intervention group
Group type: COMPARATOR
Intervention: Olaparib 300 mg twice daily alone
Number of subjects: 90
Study 36256912 — intervention group
Group type: EXPERIMENTAL
Intervention: Cediranib 30 mg once daily plus olaparib 200 mg twice daily in HRR-deficient mCRPC
Number of subjects: 90
Study 36256912 — intervention group
Group type: COMPARATOR
Intervention: Olaparib 300 mg twice daily alone in HRR-deficient mCRPC
Number of subjects: 90
Study 36256912 — intervention group
Group type: EXPERIMENTAL
Intervention: Cediranib 30 mg once daily plus olaparib 200 mg twice daily in BRCA2-mutated mCRPC
Number of subjects: 90
Study 36256912 — intervention group
Group type: COMPARATOR
Intervention: Olaparib 300 mg twice daily alone in BRCA2-mutated mCRPC
Number of subjects: 90
Study 33466699 — intervention group
Group type: EXPERIMENTAL
Intervention: Motor Imagery Training Group (MITG)
Number of subjects: 34
Study 33466699 — intervention group
Group type: EXPERIMENTAL
Intervention: Task‐Oriented Training Group (TOTG)
Number of subjects: 34
Study 33466699 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 34
Study 36181009 — intervention group
Group type: EXPERIMENTAL
Intervention: Colchicine
Number of subjects: 0
Study 36181009 — intervention group
Group type: COMPARATOR
Intervention: No colchicine (Control)
Number of subjects: 0
Study 33177220 — intervention group
Group type: EXPERIMENTAL
Intervention: Quadratus lumborum block type 3 (QLB3)
Number of subjects: 46
Study 33177220 — intervention group
Group type: COMPARATOR
Intervention: Lumbar plexus block (LPB)
Number of subjects: 46
Study 32003735 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral appliance therapy
Number of subjects: 39
Study 32003735 — intervention group
Group type: COMPARATOR
Intervention: Nasal resistance measurement
Number of subjects: 39
Study 32003735 — intervention group
Group type: COMPARATOR
Intervention: Mandibular advancement
Number of subjects: 39
Study 35148689 — intervention group
Group type: EXPERIMENTAL
Intervention: tPRK
Number of subjects: 72
Study 35148689 — intervention group
Group type: COMPARATOR
Intervention: mPRK
Number of subjects: 72
Study 35148689 — intervention group
Group type: COMPARATOR
Intervention: aaPRK
Number of subjects: 72
Study 35148689 — intervention group
Group type: COMPARATOR
Intervention: mPRK and aaPRK
Number of subjects: 72
Study 35148689 — intervention group
Group type: EXPERIMENTAL
Intervention: tPRK, mPRK, aaPRK
Number of subjects: 72
Study 33001491 — intervention group
Group type: EXPERIMENTAL
Intervention: TMFI + ALA-cream
Number of subjects: 12
Study 33001491 — intervention group
Group type: EXPERIMENTAL
Intervention: TMFI + ALA-gel
Number of subjects: 12
Study 33001491 — intervention group
Group type: COMPARATOR
Intervention: ALA-cream
Number of subjects: 12
Study 34672356 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioural medical rehabilitation
Number of subjects: 720
Study 34672356 — intervention group
Group type: COMPARATOR
Intervention: Common rehabilitation programme
Number of subjects: 720
Study 32674202 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetes Group Prenatal Care
Number of subjects: 84
Study 32674202 — intervention group
Group type: COMPARATOR
Intervention: Individual Prenatal Care
Number of subjects: 84
Study 33676327 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram using clinical features and biochemical parameters to predict DVT risk
Number of subjects: 1651
Study 33676327 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram with independent risk factors (older age ≥65 years, female gender, hemorrhagic stroke, malignancy, lower limb muscle strength <3 grade, Albumin <40 g·L−1, D‐dimer >0.5 mg·L−1)
Number of subjects: 1651
Study 33676327 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram
Number of subjects: 1651
Study 32532700 — intervention group
Group type: EXPERIMENTAL
Intervention: Food deprivation of 8 hours
Number of subjects: 37
Study 32532700 — intervention group
Group type: EXPERIMENTAL
Intervention: Food deprivation of 4 hours
Number of subjects: 37
Study 32532700 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbohydrate loading directly prior to the laparoscopic exam
Number of subjects: 37
Study 32532700 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported level of appetite (intermediate level)
Number of subjects: 37
Study 32532700 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported level of appetite (hungry)
Number of subjects: 37
Study 34713770 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive neuromuscular exercise program
Number of subjects: 30
Study 34713770 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive neuromuscular exercise program + corrective kinesio taping
Number of subjects: 30
Study 34713770 — intervention group
Group type: COMPARATOR
Intervention: Control group (exercise only)
Number of subjects: 30
Study 34886430 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical Activity Behavior Change Counseling (PABCC)
Number of subjects: 93
Study 34886430 — intervention group
Group type: COMPARATOR
Intervention: Standard exercise program (control)
Number of subjects: 93
Study 32710482 — intervention group
Group type: EXPERIMENTAL
Intervention: nsCL/P polygenic risk scores (PRS)
Number of subjects: 10448
Study 35042489 — intervention group
Group type: EXPERIMENTAL
Intervention: Kedo‐S‐Square rotary file
Number of subjects: 60
Study 35042489 — intervention group
Group type: COMPARATOR
Intervention: Hand stainless steel K file
Number of subjects: 60
Study 35042489 — intervention group
Group type: COMPARATOR
Intervention: Hand stainless steel H file
Number of subjects: 60
Study 33843663 — intervention group
Group type: EXPERIMENTAL
Intervention: Ozone therapy (OT) group, 20-25 μg/ml ozone concentration, 30 ml, 8 sessions total
Number of subjects: 38
Study 33843663 — intervention group
Group type: COMPARATOR
Intervention: Placebo control (PC) group, 0.1 μg/ml ozone concentration, 30 ml, 8 sessions total
Number of subjects: 38
Study 36455170 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixed simulation (360° virtual reality and high-fidelity simulator)
Number of subjects: 49
Study 36455170 — intervention group
Group type: COMPARATOR
Intervention: Control group (traditional simulation)
Number of subjects: 49
Study 32026271 — intervention group
Group type: EXPERIMENTAL
Intervention: Audiovisual distraction (AVD)
Number of subjects: 50
Study 32026271 — intervention group
Group type: COMPARATOR
Intervention: Patient-controlled sedation (PCS)
Number of subjects: 50
Study 32026271 — intervention group
Group type: COMPARATOR
Intervention: Historical clinician-controlled propofol usage
Number of subjects: 50
Study 32333564 — intervention group
Group type: EXPERIMENTAL
Intervention: Robot-assisted gait training + virtual reality
Number of subjects: 17
Study 32333564 — intervention group
Group type: COMPARATOR
Intervention: Standard robot-assisted gait training
Number of subjects: 17
Study 34952141 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple schedule (φ = 1)
Number of subjects: 0
Study 34952141 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixed signals (φ = 0.8, 0.4)
Number of subjects: 0
Study 34952141 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixed schedule (φ = 0)
Number of subjects: 0
Study 34952141 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 32127336 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose prasugrel (5 mg)
Number of subjects: 1408
Study 32127336 — intervention group
Group type: COMPARATOR
Intervention: Clopidogrel
Number of subjects: 1408
Study 36696208 — intervention group
Group type: EXPERIMENTAL
Intervention: Young women cluster
Number of subjects: 3062
Study 36696208 — intervention group
Group type: EXPERIMENTAL
Intervention: Young men cluster
Number of subjects: 3062
Study 36696208 — intervention group
Group type: EXPERIMENTAL
Intervention: Older people cluster
Number of subjects: 3062
Study 36696208 — intervention group
Group type: COMPARATOR
Intervention: Comorbidity cluster
Number of subjects: 3062
Study 32282356 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative riboflavin 0.10% every minute
Number of subjects: 43
Study 32282356 — intervention group
Group type: COMPARATOR
Intervention: Intraoperative riboflavin 0.10% every 2 minutes
Number of subjects: 43
Study 33579222 — intervention group
Group type: EXPERIMENTAL
Intervention: Health education sessions on obstetric danger signs and birth preparedness
Number of subjects: 300
Study 32422966 — intervention group
Group type: EXPERIMENTAL
Intervention: FeNO measurement over 28 parts per billion (pbb)
Number of subjects: 58
Study 32422966 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical evaluation of rhinitis symptoms, total immunoglobulin E (IgE), ICAM‐1, VCAM‐1, E‐selectin, and IL‐6 levels
Number of subjects: 58
Study 32422966 — intervention group
Group type: EXPERIMENTAL
Intervention: Age over 30 years
Number of subjects: 58
Study 32422966 — intervention group
Group type: EXPERIMENTAL
Intervention: Duration of allergic rhinitis over 12 months
Number of subjects: 58
Study 35776501 — intervention group
Group type: EXPERIMENTAL
Intervention: GAD-alum (4 μg) administered intralymphatically three times with 1 month interval
Number of subjects: 0
Study 35776501 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 34151951 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically predicted lipid and apolipoprotein levels (including LDL-C, triglycerides, apolipoprotein B, HDL-C)
Number of subjects: 331368
Study 34151951 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher UACR
Number of subjects: 331368
Study 34151951 — intervention group
Group type: COMPARATOR
Intervention: Reverse causal effect of eGFR
Number of subjects: 331368
Study 35869467 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive Corrective Exercise Program (CCEP) performed for three sessions per week for eight weeks
Number of subjects: 30
Study 35869467 — intervention group
Group type: COMPARATOR
Intervention: Activities of daily living (Control group)
Number of subjects: 30
Study 33568380 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone-based collaborative care intervention delivered by experienced public health nurses including detailed risk assessments, individualised structured management plans, scheduled follow-up calls, and access to a web-based app with individualised, evidence-based resources.
Number of subjects: 5229
Study 33568380 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone-based collaborative care intervention
Number of subjects: 5229
Study 32856619 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mL of a carbohydrate beverage
Number of subjects: 0
Study 32856619 — intervention group
Group type: COMPARATOR
Intervention: Pure water (control group)
Number of subjects: 0
Study 36349660 — intervention group
Group type: EXPERIMENTAL
Intervention: Energy-balanced diet
Number of subjects: 10
Study 36349660 — intervention group
Group type: COMPARATOR
Intervention: Energy-restricted diet (43 ± 3% energy deficit)
Number of subjects: 10
Study 36349660 — intervention group
Group type: EXPERIMENTAL
Intervention: Ambulatory vigilance assessment
Number of subjects: 10
Study 36349660 — intervention group
Group type: EXPERIMENTAL
Intervention: Mood assessment
Number of subjects: 10
Study 33456047 — intervention group
Group type: EXPERIMENTAL
Intervention: Lung recruitment maneuvers (RM)
Number of subjects: 42
Study 33456047 — intervention group
Group type: COMPARATOR
Intervention: Control (C)
Number of subjects: 42
Study 32446951 — intervention group
Group type: EXPERIMENTAL
Intervention: 8 mg dexamethasone before radiation therapy followed by 3 daily doses (group A)
Number of subjects: 295
Study 32446951 — intervention group
Group type: EXPERIMENTAL
Intervention: 8 mg dexamethasone followed by 3 doses of placebo (group B)
Number of subjects: 295
Study 32446951 — intervention group
Group type: COMPARATOR
Intervention: 4 doses of placebo (group C)
Number of subjects: 295
Study 35878636 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic-assisted canal wall-up (EACWU) technique
Number of subjects: 57
Study 35878636 — intervention group
Group type: COMPARATOR
Intervention: Conventional canal wall-up (CWU) technique
Number of subjects: 57
Study 35878636 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic-assisted canal wall-up (EACWU) technique in pars tensa cholesteatoma subgroup
Number of subjects: 57
Study 35878636 — intervention group
Group type: COMPARATOR
Intervention: Conventional canal wall-up (CWU) technique in pars tensa cholesteatoma subgroup
Number of subjects: 57
Study 33547676 — intervention group
Group type: EXPERIMENTAL
Intervention: ubrogepant
Number of subjects: 106
Study 33547676 — intervention group
Group type: COMPARATOR
Intervention: CGRP monoclonal antibody
Number of subjects: 106
Study 34896385 — intervention group
Group type: EXPERIMENTAL
Intervention: Menu audit and feedback plus online menu labels
Number of subjects: 19799
Study 34896385 — intervention group
Group type: COMPARATOR
Intervention: Menu audit and feedback
Number of subjects: 19799
Study 35033011 — intervention group
Group type: EXPERIMENTAL
Intervention: Abrupt discontinuation of PPI (Group A)
Number of subjects: 0
Study 35033011 — intervention group
Group type: EXPERIMENTAL
Intervention: Gradual tapering of PPI (Group B)
Number of subjects: 0
Study 32669217 — intervention group
Group type: EXPERIMENTAL
Intervention: 6% sodium chloride (hypertonic saline)
Number of subjects: 0
Study 32669217 — intervention group
Group type: COMPARATOR
Intervention: 0.12% sodium chloride (placebo)
Number of subjects: 0
Study 33321526 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal serum levels of LDL, TGs, and total cholesterol
Number of subjects: 150
Study 33321526 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal serum triglycerides (TGs)
Number of subjects: 150
Study 34772453 — intervention group
Group type: EXPERIMENTAL
Intervention: Health Education Program (HEP)
Number of subjects: 100
Study 34772453 — intervention group
Group type: COMPARATOR
Intervention: Routine health education (Control)
Number of subjects: 100
Study 33856549 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevacizumab plus topical ketorolac
Number of subjects: 50
Study 33856549 — intervention group
Group type: COMPARATOR
Intervention: Bevacizumab plus artificial tears
Number of subjects: 50
Study 33766685 — intervention group
Group type: EXPERIMENTAL
Intervention: Bubble technique (Group B)
Number of subjects: 260
Study 33766685 — intervention group
Group type: COMPARATOR
Intervention: Conventional technique (Group C)
Number of subjects: 260
Study 33501601 — intervention group
Group type: EXPERIMENTAL
Intervention: HCB (HCD supplemented with 50 mg/kg berberine)
Number of subjects: 0
Study 33501601 — intervention group
Group type: COMPARATOR
Intervention: HCD
Number of subjects: 0
Study 33501601 — intervention group
Group type: COMPARATOR
Intervention: NCD
Number of subjects: 0
Study 34533425 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinician assistants
Number of subjects: 0
Study 34533425 — intervention group
Group type: COMPARATOR
Intervention: Clinicians
Number of subjects: 0
Study 34435584 — intervention group
Group type: EXPERIMENTAL
Intervention: Dupilumab 300 mg every 2 weeks
Number of subjects: 165
Study 34435584 — intervention group
Group type: COMPARATOR
Intervention: Dupilumab 200 mg, 300 mg, 600 mg (single doses)
Number of subjects: 165
Study 34435584 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 165
Study 33855807 — intervention group
Group type: EXPERIMENTAL
Intervention: Air Anatomy hand gestures
Number of subjects: 94
Study 33855807 — intervention group
Group type: COMPARATOR
Intervention: Lecture on anatomy of extraocular muscles
Number of subjects: 94
Study 33038500 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacist intervention with bi-directional texting for BP monitoring
Number of subjects: 0
Study 36114301 — intervention group
Group type: EXPERIMENTAL
Intervention: Viewing children's faces
Number of subjects: 17
Study 32314132 — intervention group
Group type: EXPERIMENTAL
Intervention: Reverse colocated integrated care (at least two visits with a primary care provider and at least one visit with a chronic care nurse or dietician)
Number of subjects: 416
Study 32314132 — intervention group
Group type: EXPERIMENTAL
Intervention: Reverse colocated integrated care
Number of subjects: 416
Study 32005093 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain-free rehabilitation
Number of subjects: 43
Study 32005093 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain-threshold rehabilitation
Number of subjects: 43
Study 32694286 — intervention group
Group type: EXPERIMENTAL
Intervention: Second generation oral contraceptives (OC)
Number of subjects: 38
Study 32694286 — intervention group
Group type: COMPARATOR
Intervention: Non-users of oral contraceptives (non-OC)
Number of subjects: 38
Study 33881115 — intervention group
Group type: EXPERIMENTAL
Intervention: Rice bran oil (30 grams per day)
Number of subjects: 40
Study 35351035 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-month implementation strategy
Number of subjects: 100
Study 35351035 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 100
Study 33946003 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine removal of metalwork following Lisfranc injury fixation at a median time of 6 months post fixation (interquartile range 4-10)
Number of subjects: 185
Study 33946003 — intervention group
Group type: EXPERIMENTAL
Intervention: Reasons for removal of metalwork: to optimise physiological function and to reduce the risk of broken metalwork
Number of subjects: 185
Study 33946003 — intervention group
Group type: EXPERIMENTAL
Intervention: Interest in participating in a randomised controlled trial
Number of subjects: 185
Study 36424580 — intervention group
Group type: EXPERIMENTAL
Intervention: Teriparatide 20 μg subcutaneously daily for a mean of 18 months (range 14–24 months)
Number of subjects: 40
Study 36424580 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 36424580 — intervention group
Group type: EXPERIMENTAL
Intervention: Teriparatide
Number of subjects: 40
Study 33615336 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous fat grafting
Number of subjects: 13
Study 33615336 — intervention group
Group type: COMPARATOR
Intervention: Offloading and activity modification
Number of subjects: 13
Study 34314449 — intervention group
Group type: EXPERIMENTAL
Intervention: Eligible patients who were randomized (3,800 patients)
Number of subjects: 21818
Study 34314449 — intervention group
Group type: COMPARATOR
Intervention: Eligible patients who were declined for randomization (659 patients)
Number of subjects: 21818
Study 32024027 — intervention group
Group type: EXPERIMENTAL
Intervention: Sucrosomial ferric pyrophosphate plus L‐ascorbic acid (30-day oral therapy)
Number of subjects: 0
Study 32024027 — intervention group
Group type: COMPARATOR
Intervention: Control group (no supplementation)
Number of subjects: 0
Study 32327497 — intervention group
Group type: EXPERIMENTAL
Intervention: PEGasparaginase individualized dosing based on therapeutic drug monitoring
Number of subjects: 92
Study 32327497 — intervention group
Group type: EXPERIMENTAL
Intervention: PEGasparaginase during infection
Number of subjects: 92
Study 32327497 — intervention group
Group type: EXPERIMENTAL
Intervention: PEGasparaginase during induction treatment
Number of subjects: 92
Study 32327497 — intervention group
Group type: EXPERIMENTAL
Intervention: Loading dose of PEGasparaginase
Number of subjects: 92
Study 32070417 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based treatment program with therapist guidance
Number of subjects: 303
Study 32070417 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 303
Study 34299733 — intervention group
Group type: EXPERIMENTAL
Intervention: Studies using placebos
Number of subjects: 2565
Study 34299733 — intervention group
Group type: EXPERIMENTAL
Intervention: Double-blind studies
Number of subjects: 2565
Study 34299733 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple-blind studies
Number of subjects: 2565
Study 34299733 — intervention group
Group type: EXPERIMENTAL
Intervention: Crossover design studies
Number of subjects: 2565
Study 34299733 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall studies
Number of subjects: 2565
Study 34299733 — intervention group
Group type: EXPERIMENTAL
Intervention: Performance bias
Number of subjects: 2565
Study 32320457 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV self-testing kits distribution (intervention group)
Number of subjects: 400
Study 35789991 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (60,000 IU monthly for 5 years)
Number of subjects: 20334
Study 33785488 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile serious game ReValidate!
Number of subjects: 92
Study 33785488 — intervention group
Group type: COMPARATOR
Intervention: Standard care (unsupervised exercises and referral for physiotherapy or exercise therapy upon request)
Number of subjects: 92
Study 35710440 — intervention group
Group type: EXPERIMENTAL
Intervention: Clindamycin capsules for 10 days
Number of subjects: 80
Study 35710440 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 10 days
Number of subjects: 80
Study 35241469 — intervention group
Group type: EXPERIMENTAL
Intervention: Palbociclib in combination with an aromatase inhibitor (AI)
Number of subjects: 1000
Study 35241469 — intervention group
Group type: COMPARATOR
Intervention: Palbociclib in combination with fulvestrant
Number of subjects: 1000
Study 33385198 — intervention group
Group type: EXPERIMENTAL
Intervention: Hook-eye front-closure bra
Number of subjects: 60
Study 33385198 — intervention group
Group type: EXPERIMENTAL
Intervention: Zipper front-closure bra
Number of subjects: 60
Study 33385198 — intervention group
Group type: COMPARATOR
Intervention: Hook-loop front-closure bra
Number of subjects: 60